Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Pharmacology & Pharmacotherapy Volume 1 (2016), Article ID 1:IJCPP-106, 4 pages
https://doi.org/10.15344/2456-3501/2016/106
Research Article
Evaluation of Meropenem Utilization in Intensive Care Unit in Sudan

Osama M Sanhoury1 and Ahmed S Eldalo2*

1Clinical Pharmacy, College of Pharmacy, Omdurman Islamic University, Sudan
2Clinical Pharmacology, College of Pharmacy, Taif University, Saudi Arabia
Dr. Ahmed S Eldalo, Clinical Pharmacology, College of Pharmacy, Taif University, Saudi Arabia; E-mail: ahmed_dalo@hotmail.com
29 January 2016; 17 May 2016; 19 May 2016
Sanhoury OM,Eldalo AS (2016) Evaluation of Meropenem Utilization in Intensive Care Unit in Sudan. Int J Clin Pharmacol Pharmacother 1: 106. doi: https://doi.org/10.15344/2456-3501/2016/106
© 2016 Sanhoury et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Smythe MA, Melendy S, Jahns B, Dmuchowski C (1993) An exploratory analysis of medication utilization in a medical intensive care unit. Crit Care Med 21: 1319-1323 [CrossRef] [Google Scholar] [PubMed]
  2. Townsend PL, Reynolds JR, Zaske DE (1999) Applied Pharmacokinetics in the Intensive Care Unit. In, Irwin RS, CerraFB, Rippe JM (ed). Irwin and Rippe’s Intensive Care Medicine. 4th ed. Lippincott-Raven Publishers 1413
  3. Niederman MS (2003) Appropriate use of antimicrobial agents: challenges and strategies for improvement. Crit Care Med 31: 608-616 [CrossRef] [Google Scholar] [PubMed]
  4. Pulcini C, Pradier C, Samat-Long C, Hyvernat H, Bernardin G, et al. (2006) Factors associated with adherence to infectious diseases advice in two intensive care units. J Antimicrob Chemother 57: 546-550 [CrossRef] [Google Scholar] [PubMed]
  5. Srishyla MV, Krishnamurthy M, Nagarani MA, Mary CSr, Andrade C, et al. (1994) Prescription audit in an Indian hospital setting using the DDD (Defined Daily Dose) concept. Indian J Pharmacol 26: 23-28 [Google Scholar]
  6. Shahrazad M, Alireza H, Hassan T, Gholami K, Javadi MR (2013) Carbapenem Utilization in Critically Ill Patients. J Pharmceut Care 1: 141- 144 [Google Scholar]
  7. Hersh AL, Shapiro DJ, Pavia AT, Shah SS (2011) Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics 128: 1053-1061 [CrossRef] [Google Scholar] [PubMed]
  8. French GL (2005) Clinical impact and relevance of antibiotic resistance. Adv Drug Deliv Rev 57: 1514-1527 [CrossRef] [Google Scholar] [PubMed]
  9. Monroe S, Polk R (2000) Antimicrobial use and bacterial resistance. Curr Opin Microbiol 3: 496-501 [CrossRef] [Google Scholar] [PubMed]
  10. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, et al. (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44: 159- 177 [CrossRef] [Google Scholar] [PubMed]
  11. WHO (2002) Promoting rational drug use of medicines; core components. World Health Organization 1-6 [Google Scholar]
  12. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA (2010) Attributable hospital cost and length of stay associated with health careassociated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemo 54: 109- 115 [CrossRef] [Google Scholar] [PubMed]
  13. Kleinke JD (2001) The price of progress: prescription drugs in the health care market. Health Aff (Millwood) 20: 43-60 [CrossRef] [Google Scholar] [PubMed]
  14. Gupta N, Sharma D, Garg S, Bhargava V (1997) Auditing of prescriptions to study utilization of antimicrobials in a tertiary hospital. Indian J Pharmacol 29: 411 [Google Scholar]
  15. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, et al. (2000) The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18: 3038-3051 [CrossRef] [Google Scholar] [PubMed]
  16. Hurst M, Lamb HM (2000) Meropenem: a review of its use in patients in intensive care. Drugs 59: 653-680 [CrossRef] [PubMed]
  17. Farooq JA, Ajaz M, Pandita KK, Rehana KMS, Yattoo GH, et al. (2013) Drug Utilization at SKIMS-A Tertiary Care Hospital. JK-Practitioner. 18: 35- 40 [Google Scholar]
  18. John LJ, Devi P, John J, Guido S (2011) Drug Utilization Study of Antimicrobial Agents in Medical Intensive Care Unit of A Tertiary Care Hospital. Asian J Pharm Clin Res 4: 81-84 [CrossRef] [PubMed]
  19. Cunha BA (1998) Meropenem in elderly and renally impaired patients. Int J Antimicrob Agents 10: 107-117 [CrossRef] [Google Scholar] [PubMed]
  20. Jary F, Kaiser JD, Henon T, Leroy J, Patry I, et al. (2012) Appropriate use of carbapenems in the Besançon university hospital. Med Mal Infect 42: 510-516 [CrossRef] [Google Scholar] [PubMed]
  21. Cohen-Wolkowiez M, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, et al. (2012) Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections. Clin Infect Dis. 55: 1495-502 [CrossRef] [Google Scholar] [PubMed]
  22. Deresinski S (2009) Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin-Resistant Staphylococcus aureusInfections. Clin Infect Dis 49: 1072-1079 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.